Making decisions about hormone replacement therapy: Bisphosphonates should not be recommended for women aged 50

BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7403.1398-a (Published 19 June 2003) Cite this as: BMJ 2003;326:1398
  1. Susan M Ott, associate professor (smott@u.washington.edu)
  1. University of Washington, 98195 Washington, DC, USA

    EDITOR—Many people, including Rymer et al in their clinical review,1 say that bisphosphonates can be used instead of oestrogen to prevent osteoporotic fractures. Clinical trials of bisphosphonates in perimenopausal women have shown …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription